Casado E, Quesada JM, Naves M, Peris P, Jódar E, Giner M, et al. Recomendaciones de la SEIOMM en la prevención y tratamiento del déficit de vitamina D. Rev Osteoporos Metab Miner 2021;13:84-97.
Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab 2011;25:585‐91.
DOI: 10.1016/j.beem.2011.05.002
Tieland M, Brouwer‐Brolsma EM, Nienaber‐Rousseau C, van Loon LJ, de Groot LC. Low vitamin D status is associated with reduced muscle mass and impaired physical performance in frail elderly people. Eur J Clin Nutr 2013;67:1050‐5.
DOI: 10.1038/ejcn.2013.144
Bischoff HA, Stahelin HB, Urscheler N, Ehrsam R, Vonthein R, Perrig‐Chiello P, et al. Muscle strength in the elderly: Its relation to vitamin D metabolites. Arch Phys Med Rehabil 1999;80:54‐8.
DOI: 10.1016/S0003-9993(99)90307-6
Zamboni M, Zoico E, Tosoni P, Zivelonghi A, Bortolani A, Maggi S, et al. Relation between vitamin D, physical performance, and disability in elderly persons. J Gerontol A Biol Sci Med Sci 2002;57:M7‐11.
DOI: 10.1093/gerona/57.1.M7
Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 2007;92:2058‐65.
DOI: 10.1210/jc.2006-1525
Snijder MB, van Schoor NM, Pluijm SM, van Dam RM, Visser M, Lips P. Vitamin D status in relation to one‐year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 2006;91:2980‐5.
DOI: 10.1210/jc.2006-0510
Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL. Effect of vitamin D supplementation on muscle strength: A systematic review and meta‐analysis. Osteoporos Int 2011;22:859‐71.
DOI: 10.1007/s00198-010-1407-y
Howard GA, Turner RT, Sherrard DJ, Baylink DJ. Human bone cells in culture metabolize 25‐hydroxyvitamin D3 to 1, 25‐dihydroxyvitamin D3 and 24, 25‐dihydroxyvitamin D3. J Biol Chem 1981;256:7738‐40.
DOI: 10.1016/S0021-9258(18)43337-6
van Driel M, Koedam M, Buurman CJ, Hewison M, Chiba H, Uitterlinden AG, et al. Evidence for auto/paracrine actions of vitamin D in bone: 1ahydroxylase expression and activity in human bone cells. FASEB J 2006;20:2417‐9.
DOI: 10.1096/fj.06-6374fje
Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino AC, et al. Metabolism of vitamin D3 in human osteoblasts: Evidence for autocrine and paracrine activities of 1a, 25‐dihydroxyvitamin D3. Bone 2007;40:1517‐28.
DOI: 10.1016/j.bone.2007.02.024
van der Meijden K, Lips P, van Driel M, Heijboer AC, Schulten EA, den Heijer M, et al. Primary human osteoblasts in response to 25‐Hydroxyvitamin D3, 1, 25‐Dihydroxyvitamin D3 and 24R, 25‐ Dihydroxyvitamin D3. PLoS ONE 2014;9:e110283.
DOI: 10.1371/journal.pone.0110283
Bacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling‐Perry K, Gales B, et al. Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25‐ dihydroxyvitamin D in human monocytes. J Bone Miner Res 2013;28:46‐55.
DOI: 10.1002/jbmr.1740
Gómez Alonso C, Díaz López JB, Rodríguez Rebollar A, Martínez Arias L, Martín Vírgala J, Martín Carro B, et al. Niveles de calcidiol y mantenimiento de la función muscular, capacidad funcional y densidad mineral ósea en población española no seleccionada. Rev Osteoporos Metab Miner 2019;11:6-11.
Naves Díaz M, Cabezas Rodríguez I, Barrio Vázquez S, Fernández E, Díaz López JB, Cannata Andía JB. Low calcidiol levels and risk of progression of aortic calcification. Osteoporos Int 2012;23:1177‐82.
DOI: 10.1007/s00198-011-1550-0
Stavenuiter AWD, Arcidiacono MV, Ferrantelli E, Keuning ED, Vila Cuenca M, ter Wee PM, et al. A novel rat model of vitamin D deficiency: safe and rapid induction of vitamin D and calcitriol deficiency without hyperparathyroidism. Biomed Res Int 2015;2015:604275.
DOI: 10.1155/2015/604275
Alcalde-Estévez E, Sosa P, Asenjo-Bueno A, Plaza P, Valenzuela PL, Naves-Díaz M, et al. Dietary phosphate restriction prevents the appearance of sarcopenia signs in old mice. J Cachexia Sarcopenia Muscle 2023;14:1060-74.
DOI: 10.1002/jcsm.13194
Lau WL, Linnes M, Chu EY, Foster BL, Bartley BA, Somerman MJ, et al. High phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease. Nephrol Dial Transpl 2013;28:62-9.
DOI: 10.1093/ndt/gfs333
Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of aterosclerosis throughout the arterial tree. Arterioscler Thromb Vasc Biol 1994;14:133-40.
DOI: 10.1161/01.ATV.14.1.133
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta DeltaC(T)) Method. Methods 2001;25:4028.
Sohl E, van Schoor NM, de Jongh RT, Visser M, Deeg DJ, Lips P. Vitamin D status is associated with functional limitations and functional decline in older individuals. J Clin Endocrinol Metab 2013;98:E1483-90.
DOI: 10.1210/jc.2013-1698
Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003;88:5766-72.
DOI: 10.1210/jc.2003-030604
Bolland MJ, Grey A, Avenell A. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta‐analysis, and trial sequential analysis. Lancet Diabetes Endocrinol 2018;6:847‐58.
DOI: 10.1016/S2213-8587(18)30265-1
Choi M, Park H, Cho S, Lee M. Vitamin D3 supplementation modulates inflammatory responses from the muscle damage induced by high-intensity exercise in SD rats. Cytokine 2013;63:27-35.
DOI: 10.1016/j.cyto.2013.03.018
Srikuea R, Zhang X, Park-Sarge OK, Esser KA. VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation. Am J Physiol Cell Physiol 2012;303:C396-C405.
DOI: 10.1152/ajpcell.00014.2012
Stratos I, Li Z, Herlyn P, Rotter R, Behrendt AK, Mittlmeier T. Vitamin D increases cellular turnover and functionally restores the skeletal muscle after crush injury in rats. Am J Pathol 2013;182:895-904.
DOI: 10.1016/j.ajpath.2012.11.006
Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R, Stahelin HB, et al. In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 2001;33:19-24.
DOI: 10.1023/A:1017535728844
Montero-Odasso M, Duque G. Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol Aspects Med 2005;26:203-19.
DOI: 10.1016/j.mam.2005.01.005
Abboud M, Puglisi DA, Davies BN, Rybchyn M, Whitehead NP, Brock KE, et al. Evidence for a specific uptake and retention mechanism for 25-Hydroxyvitamin D (25OHD) in skeletal muscle cells. Endocrinology 2013;154:3022-30.
DOI: 10.1210/en.2012-2245
Girgis CM, Mokbel N, Minn Cha K, Houweling PJ, Abboud M, Fraser DR, et al. The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers. Endocrinology 2014;155:3227-7.
DOI: 10.1210/en.2014-1016
Girgis CM, Clifton-Bligh RJ, Mokbel N, Cheng K, Gunton JE. Vitamin D signaling regulates proliferation, differentiation, and myotube size in C2C12 skeletal muscle cells. Endocrinology 2014;155:347-57.
DOI: 10.1210/en.2013-1205
Ceglia L, Niramitmahapanya S, Morais MD, Rivas DA, Harris SS, Bischoff-Ferrari H, et al. A randomized study on the effect of vitamin D3 supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women. J Clin Endocrinol Metab 2013;98:E1927-E35.
DOI: 10.1210/jc.2013-2820
Fernández Villabrille S, Martín Carro B, Martín Vírgala J, Alonso Montes C, Fernández Fernández A, Martínez Salgado C, et al. Phosphorus may induce phenotypic transdifferentiation of vascular smooth muscle cells through the reduction of microRNA-145. Nutrients 2023;15:2918.
DOI: 10.3390/nu15132918
Chang S, Gao L, Yang Y, Tong D, Guo B, Liu L, et al. MiR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells. Oncotarget 2015;6:7675-85.
DOI: 10.18632/oncotarget.3048
Carrillo López N, Panizo S, Arcidiacono MV, de la Fuente S, Martínez Arias L, Ottaviano E, et al. Vitamin D treatment prevents uremia-induced reductions in aortic microRNA-145 attenuating osteogenic differentiation despite hyperphosphatemia. Nutrients 2022;14:2589.
DOI: 10.3390/nu14132589